- Accession Number:
- Form Type:
- Zero Holdings:
- Publication Time:
- 2012-04-26 18:44:01
- Reporting Period:
- Filing Date:
- Filing Date Changed:
- Accepted Time:
- 2012-04-26 19:44:01
- Original Submission Date:
|Cik||Name||Symbol||Sector (SIC)||IRS No|
|1060736||Seattle Genetics Inc||SGEN||Biological Products, (No Disgnostic Substances) (2836)||911874389|
|Cik||Name||Reported Address||Insider Title||Director||Officer||Large Shareholder||Other|
|1393945||C Thomas Reynolds||21823 30Th Drive Se |
Bothell WA 98021
|Chief Medical Officer||No||Yes||No||No|
|Sec. Name||Acquisiton - Disposition||Date||Amount||Price||Remaning Holdings|
|Equity Swap Involved||Form Type||Code||Nature of Ownership||Explanation|
|Sec. Name||Sec. Type||Acquisiton - Disposition||Date||Amount||Price||Amount - 2||Price - 2|
|Common Stock||Non-Qualified Stock Option (right to buy)||Disposition||2012-04-25||40,000||$0.00||40,000||$8.24|
|Remaning Holdings||Exercise Date||Expiration Date||Equity Swap Involved||Transaction Form Type||Transaction Code||Nature of Ownership|
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Reynolds on November 8, 2011.
- Amount of securities beneficially owned following reported transactions includes 27,886 Restricted Stock Units subject to vesting.
- Shares shall vest at a rate of 25% on 3/19/07 and monthly thereafter until all the shares are fully vested on 3/19/11.
Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).